Cytotoxic Activity of Glocihdium zeylanicum Leaf Extract
Srivalli Tripuramallu*, Srikanth Sunkara and Venkata
Ramana Reddy. Maram
Gitanjali
ABSTRACT
In vitro
cytotoxic activity of Glocihdium
zeylanicum has been investigated by tryphan blue dye exclusion
method at various concentrations on Ehlirich Ascites Carcinoma cells. The
ethanolic extracts of Glocihdium
zeylanicum has showed the significant cytotoxic property by inhibiting the
dye exclusion was evaluated by comparing with standard 5-Fluorouracil. The
preliminary study indicates the ethanolic extract of Glocihdium zeylanicum has significant cytotoxic property and
suggests for further investigation for its antitumor and anticarcinogenic
function in different models.
KEY WORDS: Glocihdium
zeylanicum, Cytotoxic activity, EAC cells, 5-fluorouracil
INTRODUCTION
Glochidion zeylanicum is a shrub or a small tree. It is usually found in
scrub lands and along the banks of streams. Glochidion zeylanicum is
natural vegetation to
EXPERIMENTAL:
Collection
and extraction of leaf:
The plant was collected in
Ranga Reddy district, Andhrapradesh and leaf was dried under shade for 4 days
and powdered in mechanical grinder. The leaf powder was extracted with ethanol
by combination of maceration 12 hrs and then soxhelate for 3 hrs. The combined
extracts were concentrated under rotary flash vacuum evaporator to thickness
and used for the study of cytotoxic activity.
The Glocihdium
zeylanicum, leaf organic extracts were evaluated for
invitro cytotoxicity effects by tryphan blue dye exclusion method at various
concentrations on Ehrlich Ascites Carcinoma cells. The study was conducted after obtaining
institution animal ethics committee approval.
Table 1: Cytotoxic activity of Glocihdium zeylanicum leafs extract on EAC Cells.
|
S. No. |
Concentration in microgram/mL |
Cytotoxic activity in
Percentage of inhibition |
|
|
Ethanolic extract [Test] |
5-Fluoro Uracil[Standard] |
||
|
1 |
250 |
44. 46% |
55.46% |
|
2 |
500 |
49.22% |
58.34% |
|
3 |
1000 |
50.26% |
62.35% |
|
4 |
1500 |
56.92% |
69.72% |
|
5 |
2000 |
58.6% |
76.58% |
|
6 |
IC50 [µg/mL] |
1580 µg/mL. |
250 µg/mL |
Test animal:
Adult Swiss male Albino mice (25-30gm) were procured
from CCMB,
Malignat Cell linings: -
Ehrlich Ascites Carcinoma cells were obtained through
the courtesty of CCMB,
Chemicals: -
Tryphan blue dye and DMSO [AR grade].
Phosphate buffer saline: -
Prepared by dissolving 2.5gms of sodium dihydrogen
phosphate, 2.325gms of disodium hydrogen phosphate and 8.2gms of sodium
chloride in 100ml of water.
Principle:
Tryphan blue is recommended in dye exclusion procedure
for viable cell counting based on the principle that live cells (viable)
actively pump out the dye by efflux mechanism where as dead cells (non viable)
do not.
Method:-
Male albino mice were inoculated with 1x106
EAC cells/mouse through the courtesy of CCMB till the desired growth of the
tumor in mice was notice6,7 .Cytotoxicity was assessed by incubating
1ml of peritoneal fluid (consisting of 1x106 EAC cells with a cell
viability beyond 60%) in 1 ml phosphate buffer saline and 1ml of varying
concentrations (250,500,1000,1500,2000µg/ml)of the test extracts of Glocihdium
zeylanicum (Ethanolic) at 37oC for 3 hr in CO2
atmosphere, using Mclntosh field jar.
The viability of the cells was determined by tryphan blue dye exclusion
method. The equal proportion of
incubated EAC cells and tryphan blue dye (10%in water) were mixed and kept
aside. After 10 min the total number of
viable and non viable were (dead cells take up the dye whereas viable cells
exclude the dye) counted by using newbaurs chamber 5-Fluorouracil was used as
standard drug and Ethanol as a control.
The percentage of dead cells was calculated using the formula from which
IC50 concentration was determined.
RESULTS AND DISCUSSIONS:
A number of natural products have been studied for
anticancer activity in various experimental models. A reliable criteria for judging of anticancer
activity in prolongation of life span and decrease of WBC from blood 8,9
. A preliminary attempt was made to assess the invitro
cytotoxic properties of Glocihdium
zeylanicum extracts on Ehrlich Ascites Carcinoma (EAC) cells
at varying concentrations 250, 500,1000, 1500and 2000 µg/ml. 5-fluorouracil is
used as a reference standard and Ethanol is used as control. The number of viable and nonviable cells was
counted by using Tryphan blue exclusion method.
The table 1-illustrates the activity of Glochidium zeylanicum leaf extract
against EAC cells. The activity of 5-fluorouracil at varying concentrations is
comparatively very high with respect to Glochidium
zeylanicum leaf extract. The decreasing % inhibition [IC50]
cytotoxicity activity is in order of 5-flourouracil [250 µg/mL]> Ethanolic
extract of Glochidium zeylanicum [1580 µg/mL]. These preliminary
study results indicate that ethanolic extract suggests for further
investigation for its antitumour and cytotoxic properties in different
experimental models.
CONCLUSION:
The present study revealed that the leaf
extract of Glochidium zeylanicum possess the significant cytotoxic
activity and the further pharmacological investigations are required for evaluation
of potential benefits as natural anticancer agent in different experimental
models.
REFERENCES:
1.
Nakata
F., Nakata K., “Medicinal Plants,” Shinsei Press Ltd., Naha, Okinawa, 1991;
Tawada S., Ohta F., “Encyclopedia of Medicinal Plants in Okinawa,” Shinsei
Press Ltd., Naha, Okinawa, 1985.
2.
Otsuka
H., Hirata E., Takushi A., Shinzato T., Takeda Y., Bando M., Kido M., Chem.
Pharm. Bull., 48, 547—551
(2000).
3.
Morita
N., Arisawa M., Yoshikawa A., Yakugaku Zasshi, 96, 1180—1183 (1976).
4.
Komatsu
M., Tomimori T., Makiguchi Y., Chem. Pharm. Bull., 15,1567—1572 (1967).
5.
Hideaki
OTSUKA,* Hidehiko KIJIMA, Eiji HIRATA, Takakazu SHINZATO,
Anki TAKUSHI, Masahiko BANDO, and Yoshio TAKED, Chem.
Pharm. Bull. 51(3) 286—290
(2003) Vol. 51, No. 3.
6.
Sheeja KR, Kuttan G, and Kuttan R, Amala ResBull, 17, 1997, 3
7.
Rajkapoor B, Jayakar B, and Murugesh N, Ind.J Pharmacology, 36,
2004, 38.
8.
Clarkson BDand Burchenal JH. Prog.Clin Cancer, 1, 1965, 6259
9.
Oberling C and Guerin M. Adv. Cancer Res, 2, 1954, 353.
Received on 27.10.2009
Accepted on 18.11.2009
© A&V Publication all right reserved
Research J. Pharmacology and
Pharmacodynamics 1(3) Nov - Dec. 2009; 145-146